Possible Utility for a Renal Tumor Capsule Invasion Scoring System

Share this content:
The Capsule Invasion Scoring System (i-Cap) may be a useful marker with clinical implications.
The Capsule Invasion Scoring System (i-Cap) may be a useful marker with clinical implications.

The Capsule Invasion Scoring System (i-Cap), which measures the degree to which a renal tumor invades a pseudocapsule, may be a useful marker with clinical implications, according to an article published in The Journal of Urology.1

Researchers evaluated 327 tumors that were removed via nephrectomy; pseudocapsule invasion was measured using the i-Cap system to determine the clinical consequences of using the scoring system.

Pseudocapsule invasion levels were compared with the surgical techniques used to resect the tumors. Tumors removed by enucleation did not have higher i-Cap scores, though the pseudocapsule rims of these tumors were thinner. High rates of capsular invasion were observed at similar levels regardless of variety of surgery.

RELATED: First-line Sunitinib and Pazopanib Are Similarly Effective on mRCC

Complete invasion was associated with papillary or higher tumor grades.

The authors concluded that the i-Cap system should be investigated further to determine the association between capsular invasion and oncological outcome.


  1. Snarskis C, Calaway AC, Wang L, et al. Standardized reporting of microscopic renal tumor margins: introduction of the renal tumor capsule invasion (i-Cap) scoring system. J Urol. In press. 

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs